This mechanism was partially validated in an AD mouse model, where a proteolytically overactivated form of DYRK1A, which becomes truncated in a Ca2+-dependent manner and exhibits high affinity for STAT, accumulates in astrocytes. Here, SOAT1 is linked to Alzheimer disease.